会计Accountant
和铂医药(上海)有限责任公司
- 公司规模:150-500人
- 公司性质:外资(欧美)
- 公司行业:制药/生物工程
职位信息
- 发布日期:2019-11-14
- 工作地点:上海-徐汇区
- 招聘人数:1人
- 工作经验:无工作经验
- 学历要求:招1人
- 语言要求:不限
- 职位月薪:0.6-1.1万/月
- 职位类别:会计
职位描述
1. 负责在SAP系统编制和登记各类明细账、总账并定期结账,包括固定资产、应收应付、存货等模块
2. 熟悉SAP系统三单匹配操作,能结合业务实际对付款单据进行审核和匹配,以执行应付操作
3. 负责公司费用核算和审核费用单据,能按照集团要求控制和管理各项费用开支,并按部门归集、分配各项管理费用,编制各部门费用明细表,定期进行纵向分析。
4. 监督业务部门在系统内的单据操作,保证公司各项运营流程的按照规定执行和实施
5. 负责固定资产的记录和管理,定期实施固定资产盘点。
6. 按月装订和整理会计资料。
7. 实施和监督存货盘点工作。
8. 完成上级交代的其它工作。
任职资格:
1.为人正直、诚实守信
2.财务会计相关专业大专及以上学历,熟练掌握和使用SAP软件
3.三年以上企业财务会计工作经验,有生物医药公司经验优先,有创业公司经验优先,能适应创业企业快节奏工作环境
4.具有较强的敬业精神和主动性,具备快速学习能力和承压能力
职能类别:会计
关键字:Accountant会计
公司介绍
和铂医药是一家专注于肿瘤免疫领域创新药物研究与开发的全球化运营生物医药公司。公司将运用其拥有的全部自主知识产权的全人源单抗的转基因鼠系列核心技术平台,建立下一代治疗性肿瘤抗体药物产品管线,并将围绕Harbour的两大平台拓展合作与授权业务。公司总部及研发基地位于中国上海,另外在美国马塞诸塞州剑桥设立商业运营中心,在荷兰鹿特丹设立抗体研发平台创新中心,在波士顿地区设立了创新中心包括实验室和研发团队,也将在江苏昆山设立研发基地。公司拥有资深管理团队以及丰富的药物研究与开发经验。和铂医药要为满足中国及全球病人的需求而不断努力,依托拥有自主知识产权的核心技术平台,创建一个在肿瘤治疗领域有科学与技术领导力的国际性生物医药公司。同时, 在药物研发领域建立以技术平台为基础的对外合作,整合新的技术,推动中国整个抗体研发产业的进步。
Company Overview
Harbour BioMed is a global biotechnology company discovering and developing innovative therapeutics for cancer with a focus on immuno-oncology and autoimmunity/inflammation. The company's discovery and development programs are centered around its two patented transgenic mouse platforms for human antibody discovery.
The company is building its proprietary pipeline internally, through collaborations with co-development partners, as well as through selective preclinical and clinical stage asset acquisitions. Harbour BioMed also licenses the platforms to companies and academic institutions through its Harbour Antibodies subsidiary.
Harbour BioMed has headquarters and an R&D site in Shanghai, business operations in Cambridge, MA, and antibody platform development in Rotterdam, The Netherlands.
The company has an innovation center including research lab and a development team in Boston. Also, we are expanding to Kunshan site in Jiangsu for our R&D operation.
Company Overview
Harbour BioMed is a global biotechnology company discovering and developing innovative therapeutics for cancer with a focus on immuno-oncology and autoimmunity/inflammation. The company's discovery and development programs are centered around its two patented transgenic mouse platforms for human antibody discovery.
The company is building its proprietary pipeline internally, through collaborations with co-development partners, as well as through selective preclinical and clinical stage asset acquisitions. Harbour BioMed also licenses the platforms to companies and academic institutions through its Harbour Antibodies subsidiary.
Harbour BioMed has headquarters and an R&D site in Shanghai, business operations in Cambridge, MA, and antibody platform development in Rotterdam, The Netherlands.
The company has an innovation center including research lab and a development team in Boston. Also, we are expanding to Kunshan site in Jiangsu for our R&D operation.
联系方式
- Email:joyce.xia@harbourbiomed.com
- 公司地址:地址:span北京市建国路118号招商局大厦2楼A01室